VISTAGEN THERAPEUTICS, INC. Payments to Acquire Machinery and Equipment
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Payments to Acquire Machinery and Equipment of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMachineryAndEquipment · last filed 2026-08-14
- VISTAGEN THERAPEUTICS, INC. payments to acquire machinery and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. payments to acquire machinery and equipment for the quarter ending 2025-12-31 was $26.00K.
- VISTAGEN THERAPEUTICS, INC. payments to acquire machinery and equipment for the quarter ending 2025-09-30 was $60.00K, a 1.64% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. payments to acquire machinery and equipment for the quarter ending 2025-06-30 was $65.00K, a 54.76% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. payments to acquire machinery and equipment for fiscal 2014 was -$9.60K, a 107.09% decline from fiscal 2013.
- VISTAGEN THERAPEUTICS, INC. payments to acquire machinery and equipment for fiscal 2013 was $135.40K, a 317.90% increase from fiscal 2012.
- VISTAGEN THERAPEUTICS, INC. payments to acquire machinery and equipment for fiscal 2012 was $32.40K, a 43.94% decline from fiscal 2011.
- VISTAGEN THERAPEUTICS, INC. payments to acquire machinery and equipment for fiscal 2011 was $57.80K.
| Period end | Payments to Acquire Machinery and Equipment 3 month | Payments to Acquire Machinery and Equipment 3 month as first filed | Payments to Acquire Machinery and Equipment 6 month | Payments to Acquire Machinery and Equipment 6 month as first filed | Payments to Acquire Machinery and Equipment 9 month | Payments to Acquire Machinery and Equipment 9 month as first filed | Payments to Acquire Machinery and Equipment 12 month | Payments to Acquire Machinery and Equipment 12 month as first filed | Payments to Acquire Machinery and Equipment 157 month | Payments to Acquire Machinery and Equipment 160 month | Payments to Acquire Machinery and Equipment 163 month | Payments to Acquire Machinery and Equipment 166 month | Payments to Acquire Machinery and Equipment 169 month | Payments to Acquire Machinery and Equipment 172 month | Payments to Acquire Machinery and Equipment 175 month | Payments to Acquire Machinery and Equipment 178 month | Payments to Acquire Machinery and Equipment 181 month | Payments to Acquire Machinery and Equipment 184 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |||||||||||||||||
| 2025-12-31 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $86.00K derived: sum of 2 quarters · filed 2026-02-12 | $151.00K 10-Q · filed 2026-02-12 | |||||||||||||||
| 2025-09-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $125.00K 10-Q · filed 2025-11-13 | ||||||||||||||||
| 2025-06-30 | $65.00K 10-Q · filed 2026-08-14 | |||||||||||||||||
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $61.00K derived: sum of 2 quarters · filed 2026-02-12 | $103.00K 10-Q · filed 2026-02-12 | |||||||||||||||
| 2024-09-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $103.00K 10-Q · filed 2025-11-13 | ||||||||||||||||
| 2024-06-30 | $42.00K 10-Q · filed 2025-08-07 | |||||||||||||||||
| 2023-12-31 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $32.00K derived: sum of 2 quarters · filed 2025-02-13 | $32.00K 10-Q · filed 2025-02-13 | |||||||||||||||
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||||||||||||||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | |||||||||||||||||
| 2020-12-31 | $151.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | $249.90K 10-Q · filed 2021-02-11 | ||||||||||||||||
| 2020-09-30 | $98.80K 10-Q · filed 2020-11-12 | |||||||||||||||||
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | $0.00 10-Q · filed 2021-02-11 | ||||||||||||||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | |||||||||||||||||
| 2017-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-12 | $1.60K derived: sum of 2 quarters · filed 2018-02-12 | $1.60K 10-Q · filed 2018-02-12 | |||||||||||||||
| 2017-09-30 | $1.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | $1.60K 10-Q · filed 2017-11-09 | ||||||||||||||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 | |||||||||||||||||
| 2016-12-31 | $2.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-12 | $7.90K derived: sum of 2 quarters · filed 2018-02-12 | $9.90K 10-Q · filed 2018-02-12 | |||||||||||||||
| 2016-09-30 | $5.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | $7.70K 10-Q · filed 2017-11-09 | ||||||||||||||||
| 2016-06-30 | $2.00K 10-Q · filed 2017-08-14 | |||||||||||||||||
| 2015-12-31 | $4.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-13 | $4.60K derived: sum of 2 quarters · filed 2017-02-13 | $4.60K 10-Q · filed 2017-02-13 | |||||||||||||||
| 2015-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | ||||||||||||||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-12 | |||||||||||||||||
| 2014-03-31 | -$19.20K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-29 | -$43.30K derived: sum of 2 quarters · filed 2015-06-29 | -$19.20K derived: sum of 3 quarters · filed 2015-06-29 | -$9.60K 10-K · filed 2015-06-29 | $9.60K 10-K · filed 2014-06-25 | $825.80K 10-K · filed 2014-06-25 | ||||||||||||
| 2013-12-31 | -$24.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | $0.00 derived: sum of 2 quarters · filed 2015-02-17 | $9.60K 10-Q · filed 2015-02-17 | -$9.60K 10-Q · filed 2014-02-14 | $276.10K derived: sum of 4 quarters · filed 2015-02-17 | -$825.80K 10-Q · filed 2014-02-14 | ||||||||||||
| 2013-09-30 | $24.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-19 | $33.70K 10-Q · filed 2014-11-19 | $300.20K derived: sum of 3 quarters · filed 2014-11-19 | $849.90K 10-Q · filed 2013-11-14 | ||||||||||||||
| 2013-06-30 | $9.60K 10-Q · filed 2014-08-12 | -$9.60K 10-Q · filed 2013-08-14 | $276.10K derived: sum of 2 quarters · filed 2014-08-12 | -$825.80K 10-Q · filed 2013-08-14 | ||||||||||||||
| 2013-03-31 | $266.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | $135.40K 10-K · filed 2014-06-25 | $816.20K 10-K · filed 2013-07-18 | |||||||||||||||
| 2012-12-31 | -$131.10K 10-Q · filed 2014-02-14 | $131.10K 10-Q · filed 2013-02-14 | $811.90K 10-Q · filed 2013-02-14 | |||||||||||||||
| 2012-09-30 | $680.80K 10-Q · filed 2012-11-14 | |||||||||||||||||
| 2012-06-30 | $680.80K 10-Q · filed 2012-08-14 | |||||||||||||||||
| 2012-03-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-18 | $24.60K derived: sum of 2 quarters · filed 2013-07-18 | $32.40K 10-K · filed 2013-07-18 | $680.80K 10-K · filed 2012-07-02 | ||||||||||||||
| 2011-12-31 | $5.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | $13.40K 10-Q · filed 2013-02-14 | $13.36K 10-Q · filed 2012-02-14 | $661.75K 10-Q · filed 2012-02-14 | ||||||||||||||
| 2011-09-30 | $7.80K 10-Q · filed 2012-11-14 | $7.81K 10-Q · filed 2011-11-14 | $656.20K 10-Q · filed 2011-11-14 | |||||||||||||||
| 2011-06-30 | $648.39K 10-Q · filed 2011-08-22 | |||||||||||||||||
| 2011-03-31 | $46.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02 | $52.34K derived: sum of 2 quarters · filed 2012-07-02 | $52.34K derived: sum of 3 quarters · filed 2012-07-02 | $57.80K 10-K · filed 2012-07-02 | ||||||||||||||
| 2010-12-31 | $52.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14 | $52.29K derived: sum of 2 quarters · filed 2012-02-14 | $57.75K 10-Q · filed 2012-02-14 | |||||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14 | $5.46K 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2010-06-30 | $5.46K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |